Affiliations (Universities & Colleges): Joseph Dalo

Affiliations (Universities & Colleges): Joseph Dalo

Affiliations (Universities & Colleges): Joseph Dalo

Association & Society Membership: Joseph Dalo

Association & Society Membership: Joseph Dalo
Worked with 120 members at a time and other organizations with the use of communication and time management, determined budgeting, location, and transportation that allowed members to connect with each other and other members of other organizations. 

Clinicals / Clerkships / Externships: Joseph Dalo
NWH - June/July - Gen Med and Health Systems 
BI - August - Regulatory Industry
Nuvance - September - Health Systems
BGB Group - Octobor - Medical Writing 
CVS Pharmacy - January - Retail 
UConn Health - Feburary - Ambulatory Care 
St Vincents Pharmacy - March - retail 
NWH - April - Oncology 

Clinicals / Clerkships / Externships: Joseph Dalo
All current APPE rotations are listed in my CV along with other information in other sections. If you are looking for most up to date information on my please refer to my CV since it has notable presentation information, sites I rotated through, and other notable experiences. 

Clinicals / Clerkships / Externships: Joseph Dalo

Clinicals / Clerkships / Externships: Joseph Dalo

Clinicals / Clerkships / Externships: Joseph Dalo

Educational Background: Joseph Dalo

Educational Background: Joseph Dalo

Goals (Personal & Professional): Joseph Dalo
Career goal: Have the largest positive impact I can in my career. Be proud of what I do everyday. Be professional.

Short Term: Enjoy my last few weeks as a student and appreciate the growth I've made as an individual. 

Goals (Personal & Professional): Joseph Dalo
Obtain 2024-2025/6 Medical Affairs Fellowship 
- Update: Got it
Graduate with PharmD May 2024
- Up next

Goals (Personal & Professional): Joseph Dalo
Specific, Measurable, Achievable, Relevant, and Time-Bound

1. Complete 2 projects during my Industry rotation in a 30 days period that meets expectations of my preceptor Roy Walton in August. This will make me a more competitive applicant for the future job/education search.

2. Present materials I have worked on with Dr. White during ACHP Mid Year event in December in Anaheim California. During the APPE school year I will work on creating a concise project to present on the already gathered information.

3. Make at least 10 meaningful connections during the entirety of P4 year to encoruage best practice and success in my future career. 

Goals (Personal & Professional): Joseph Dalo

1. Wake up no later than 7am every day regardless of daily plans.

 

2. Secure research oppertunity with UConn SoP faculty member 

 

3. Form meaningful connections with faculty 

Goals (Personal & Professional): Joseph Dalo

Proessional Goal: Learn to consuel patients in the best possible way no matter the situation.

Personal: Wake up at 6am everyn morning and start a daily routine

Honors & Awards: Joseph Dalo
I do not hold any professional awards or honors. 

Leadership: Joseph Dalo

Leadership: Joseph Dalo

Licenses & Certifications: Joseph Dalo

Licenses & Certifications: Joseph Dalo

Licenses & Certifications: Joseph Dalo

Licenses & Certifications: Joseph Dalo

My Bio: Joseph Dalo
Joe Dalo is a highly organized and motivated recent graduate from the University of Connecticut with a Bachelor of Science in Pharmacy Studies. He is due to graduate in 2024 spring with his PharmD and has accepted a post doctoral fellowship position. He possesses exceptional teamwork abilities and a demonstrated understanding of industrial pharmaceutical practices. He aims to secure a challenging role in the pharmaceutical industry that will allow him to utilize these skills.

Joe Dalo is a licensed pharmacy intern in Connecticut and New York, certified in cardiopulmonary resuscitation and immunization. He has gained experience in the pharmaceutical industry through his internships at Westchester Medical Center, Walgreens, and CVS Pharmacy. At Westchester Medical Center, he collaborated with a team of pharmacists to support clinical trials of new medications, applying his knowledge of pharmaceutical regulations and guidelines to maintain adherence to FDA regulations and guidelines. 

Joe Dalo has also gained research and publication experience at the University of Connecticut. He reviewed, analyzed, and interpreted data from over 50 reviews to assemble into a complete review article on "Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy." He also interpreted data from 17 smaller-sized studies. He concluded promising results for psychedelic drugs for anxiety and depression in cancer patients, resulting in the publication of "Psychedelics for Patients with Life-Threatening Cancer: A Comprehensive Review" by the Annals of Pharmacotherapy.

In addition to his professional experience, Joe has held leadership positions in the Pharmacy Debate Club, Phi Delta Theta Fraternity, and Pharmacy Student Government, serving as PSG Representative and Co-Founder, Vice President of Social Affairs, and Class Representative, respectively. He is also a member of the Industry Pharmacists Organization.

Presentations: Joseph Dalo
AI in Pharmaceutical Industry 
Regulatory Intelligence Network 
Changes to FDA froms 1561
- I do not have these presentations as this was specific to Boehringer Ingelheim and I said a NDA

Cefazolin 
Vancomycin 
- These presntations had specific patient information and encounters. 

Mantle Cell Lymphoma
- Patient specific info

Antidepressants with documented efficacy in Postpartum depression

**I also did a few final round interview presentations for fellowships but these were drug specific for the company based on phase 3 or a competitors medication. This was not very educational. 

If any issues without uploading these please reach out and I will remove any specific information.

Publications: Joseph Dalo
Listed in my CV

Research Experience & Interests: Joseph Dalo

White, C. M., Weisman, N., & Dalo, J. (2023). Psychedelics for Patients with Cancer: A Comprehensive Literature Review. The Annals of Pharmacotherapy.

• A comprehensive literature review highlighting the potential uses of already well-researched drug products
• Reviewed and connected over 140 research articles in order to assess the role of psychedelics in treatment of anxiety or depression among patients with cancer
• Top 1% of all research outputs insights ever scored by Altmetric and #1 paper scored by Altmetrics for two consecutive months and picked up by 43 unique news outlets, 2 blogs, and seen by more than ten thousand Twitter users

 

Dalo, J. D., Weisman, N. D., & White, C. M. (2023). Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy. The Annals of Pharmacotherapy.

• First-authored a review of a first-in-class medication used to treat obstructive hypertrophic cardiomyopathy.
• Reviewed the mechanism of action, the pharmacokinetic drug interactions, clinical trial endpoints and gave an opinion of the relevance to clinical practice and economic evaluation of a new medication

• Worked in a group with a distinguished professor and a peer in serving as a key contributor in maintaining timelines, discussing goals, and areas to improve

 

Hernandez, A. V., Hwang, J., Nasreen, I., Sicignano, D., Pasupuleti, V., Snow-Caroti, K., Weisman, N., Dalo, J., & White, C. M. (2023). Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis. Journal of Dietary Supplements.

• A systematic review and meta-analysis of the dietary supplement berberine’s effects on lipoprotein, triglyceride, and biological safety markers
• Compared berberine to current best practice medications (e.g., PCSK9 inhibitors).
• Collected, managed and organized over 12,000 patient-data points from over 200 research articles for meta-analysis.  

 

Dalo, J., Stefanie C. Nigro, P., & Langlais, H. (2023). Interactive Case Studies. Pharmacy Times. 59:8

• Authored a patient case example published in the Pharmacy Times addressing popular topics and common questions requested by retail pharmacists
• Collaborated with a clinical pharmacist, utilizing current practice guidelines, to stimulate a clinical scenario and provide correct response with the goal educating retail pharmacists
• Started discussion in healthcare community regarding pain management for moderate to severe pain while engaging audience in adverse reaction related management

 

White, C., Dalo, J., & Weisman, N. (2022). Infectious Disease Special Edition. Don’t go Breakin’ my Heart: Caring for Cardiovascular Issues in Patients With HIV

• A review article to educate care detailing the risks of cardiovascular disease in patients with HIV.
• Reviewed 28 research articles and used the information to make generalized trends in the healthcare field 
• Provided scientific information within the medical community on a topic that was lacking guidance

Resume & CV: Joseph Dalo
231018093635_Dalo_Joseph_CV_RPIF.pdf (.pdf) 0.13mb